<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14914">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01855308</url>
  </required_header>
  <id_info>
    <org_study_id>UCD 307021</org_study_id>
    <nct_id>NCT01855308</nct_id>
  </id_info>
  <brief_title>Single Site Robotic Cholecystectomy in Non Selected Patients</brief_title>
  <acronym>SSRC</acronym>
  <official_title>Single Site Robotic Cholecystectomy in Non Selected Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study of new technology to allow gallbladder removal through a single small
      surgical incision.  A surgical robot is utilized to help navigate the small space. In this
      study, patient characteristics are broad to assess how applicable the procedure is to
      everyone.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Completion of procedure by SSRC</measure>
    <time_frame>At time of surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events to study participants (e.g. bile duct injury, hemorrhage)</measure>
    <time_frame>At time of procedure and in clinic up to 30 days after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cholelithiasis</condition>
  <arm_group>
    <arm_group_label>Single site robotic chole</arm_group_label>
    <description>Cholecystectomy performed through a single incision with the robot.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single site robotic chole</intervention_name>
    <description>Cholecystectomy via the daVinci single site platform.</description>
    <arm_group_label>Single site robotic chole</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who are referred to the surgery program with non-emergency gallbladder
        disease, for which cholecystectomy is indicated, will be given the opportunity to
        participate. Referred patients typically come from the primary care setting.  The
        demographic composition of the study population will depend in the patient referred to the
        program.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of symptomatic gallstones

        Exclusion Criteria:

          -  significant previous open abdominal surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed R Ali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 15, 2013</lastchanged_date>
  <firstreceived_date>May 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Davis</investigator_affiliation>
    <investigator_full_name>Mohamed Ali, MD</investigator_full_name>
    <investigator_title>Associate Professor of Surgery</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
